- Ongoing, recruitingTherapeutic exploratory (Phase II)
Exploratory study evaluating the relevance of [68Ga]Ga-PentixaFor for initial staging and detection of minimal residual disease in multiple myeloma patients eligible for autologous stem cell transplantation less than 66 years included in the prospective IFM 2020-02.
For: Multiple MyelomaFrance - Ongoing, recruitingTherapeutic exploratory (Phase II)
Intravenous vs. Intraosseous Vascular Access During Out-of-Hospital Cardiac Arrest – A Randomized Clinical Trial
For: Out-of-hospital cardiac arrest (OHCA)Denmark - Ongoing, recruitingTherapeutic confirmatory (Phase III)
A three-year, multi-center, double-blind, extension study to evaluate the long-term safety and efficacy of ligelizumab in patients who completed ligelizumab’s Phase III studies in food allergy
For: Food allergyNetherlands · France · Spain - Ongoing, recruitingPhase I and Phase II (Integrated)- Other
A Phase 1b/2a, Dose Escalation Trial of Safety, Pharmacokinetic/Pharmacodynamic and Preliminary Clinical Activity of Briquilimab in Adult Patients with Chronic Inducible Urticaria (CIndU) Who Remain Symptomatic Despite Treatment with H1-Antihistamines
For: Chronic Inducible UrticariaGermany - Ongoing, recruitingPhase I and Phase II (Integrated)- Other
A Phase I/II Open-label, Multi-center Study to Assess Safety, Tolerability, Pharmacokinetics and Preliminary Efficacy of AZD7789, an anti-PD-1 and anti-TIM-3 Bispecific Antibody, in Patients with Relapsed or Refractory Classical Hodgkin Lymphoma
For: Relapsed/Refractory Classical Hodgkin LymphomaItaly · Denmark · Spain